BackApogee Therapeutics Overview

Apogee Therapeutics Other Current Assets

Apogee Therapeutics's other current assets is $20M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$19.81M
↑ 201.66% YoYΔ $13.24M vs prior year quarter

Peer average / median

Loading

Apogee Therapeutics Other Current Assets History

Loading

Apogee Therapeutics vs. peers: Other Current Assets Comparison

Loading

Apogee Therapeutics Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Apogee Therapeutics (APGE) FAQ

As of the most recent data (June 2026), APGE shows a other current assets of $20M. That compares with $6.6M in the prior-year period — up 201.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, APGE's other current assets is now $20M (was $6.6M) — a 201.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Apogee Therapeutics is outperforming or lagging.

Tracking APGE's other current assets over time shows whether Apogee Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $20M That compares with $6.6M in the prior-year period — up 201.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Apogee Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $20M) with ownership activity and broader fundamentals.